Interim Data Update from Phase II ALTITUDE® Trial of ABBV-RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery; AAO 2023 Nov 06, 2023 at 8:30 AM EST Click here for webcast Supporting Materials REGENXBIO Interim Data Update from Phase II ALTITUDE® Trial of ABBV-RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery Presentation - AAO 2023 956.8 KB
REGENXBIO Interim Data Update from Phase II ALTITUDE® Trial of ABBV-RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery Presentation - AAO 2023 956.8 KB